These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 24573600)

  • 41. In silico, theoretical biointerface analysis and in vitro kinetic analysis of amine compounds interaction with acetylcholinesterase and butyrylcholinesterase.
    Kandasamy S; Loganathan C; Sakayanathan P; Karthikeyan S; Stephen AD; Marimuthu DK; Ravichandran S; Sivalingam V; Thayumanavan P
    Int J Biol Macromol; 2021 Aug; 185():750-760. PubMed ID: 34216669
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Development of 3D-QSAR Model for Acetylcholinesterase Inhibitors Using a Combination of Fingerprint, Molecular Docking, and Structure-Based Pharmacophore Approaches.
    Lee S; Barron MG
    Toxicol Sci; 2015 Nov; 148(1):60-70. PubMed ID: 26202430
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The 'aromatic patch' of three proximal residues in the human acetylcholinesterase active centre allows for versatile interaction modes with inhibitors.
    Ariel N; Ordentlich A; Barak D; Bino T; Velan B; Shafferman A
    Biochem J; 1998 Oct; 335 ( Pt 1)(Pt 1):95-102. PubMed ID: 9742217
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Targeted oxidation of Torpedo californica acetylcholinesterase by singlet oxygen: identification of N-formylkynurenine tryptophan derivatives within the active-site gorge of its complex with the photosensitizer methylene blue.
    Triquigneaux MM; Ehrenshaft M; Roth E; Silman I; Ashani Y; Mason RP; Weiner L; Deterding LJ
    Biochem J; 2012 Nov; 448(1):83-91. PubMed ID: 22888904
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Design, synthesis, and evaluation of 7H-thiazolo-[3,2-b]-1,2,4-triazin-7-one derivatives as dual binding site acetylcholinesterase inhibitors.
    Liu S; Shang R; Shi L; Zhou R; He J; Wan DC
    Chem Biol Drug Des; 2014 Aug; 84(2):169-74. PubMed ID: 24890706
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Complexes of alkylene-linked tacrine dimers with Torpedo californica acetylcholinesterase: Binding of Bis5-tacrine produces a dramatic rearrangement in the active-site gorge.
    Rydberg EH; Brumshtein B; Greenblatt HM; Wong DM; Shaya D; Williams LD; Carlier PR; Pang YP; Silman I; Sussman JL
    J Med Chem; 2006 Sep; 49(18):5491-500. PubMed ID: 16942022
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Structural determinants of the multifunctional profile of dual binding site acetylcholinesterase inhibitors as anti-Alzheimer agents.
    Galdeano C; Viayna E; Arroyo P; Bidon-Chanal A; Blas JR; Muñoz-Torrero D; Luque FJ
    Curr Pharm Des; 2010; 16(25):2818-36. PubMed ID: 20698824
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Substrate and product trafficking through the active center gorge of acetylcholinesterase analyzed by crystallography and equilibrium binding.
    Bourne Y; Radic Z; Sulzenbacher G; Kim E; Taylor P; Marchot P
    J Biol Chem; 2006 Sep; 281(39):29256-67. PubMed ID: 16837465
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Lessons from functional analysis of AChE covalent and noncovalent inhibitors for design of AD therapeutic agents.
    Barak D; Ordentlich A; Kaplan D; Kronman C; Velan B; Shafferman A
    Chem Biol Interact; 2005 Dec; 157-158():219-26. PubMed ID: 16289124
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Active-site gorge and buried water molecules in crystal structures of acetylcholinesterase from Torpedo californica.
    Koellner G; Kryger G; Millard CB; Silman I; Sussman JL; Steiner T
    J Mol Biol; 2000 Feb; 296(2):713-35. PubMed ID: 10669619
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Molecular docking study on the "back door" hypothesis for product clearance in acetylcholinesterase.
    Alisaraie L; Fels G
    J Mol Model; 2006 Feb; 12(3):348-54. PubMed ID: 16341717
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Binding of the neurotoxin fasciculin 2 to the acetylcholinesterase peripheral site drastically reduces the association and dissociation rate constants for N-methylacridinium binding to the active site.
    Rosenberry TL; Rabl CR; Neumann E
    Biochemistry; 1996 Jan; 35(3):685-90. PubMed ID: 8547248
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Allosteric control of acetylcholinesterase catalysis by fasciculin.
    Radić Z; Quinn DM; Vellom DC; Camp S; Taylor P
    J Biol Chem; 1995 Sep; 270(35):20391-9. PubMed ID: 7657613
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Molecular docking and receptor-specific 3D-QSAR studies of acetylcholinesterase inhibitors.
    Deb PK; Sharma A; Piplani P; Akkinepally RR
    Mol Divers; 2012 Nov; 16(4):803-23. PubMed ID: 22996404
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Design of acetylcholinesterase inhibitor for Alzheimer's disease therapy: from multi-binding site inhibitors to multi-target directed ligands].
    Yang WC; Sun Q; Yu NX; Zhu XL; Yang GF
    Yao Xue Xue Bao; 2012 Mar; 47(3):313-21. PubMed ID: 22645754
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Identification of molecular descriptors for design of novel Isoalloxazine derivatives as potential Acetylcholinesterase inhibitors against Alzheimer's disease.
    Gurung AB; Aguan K; Mitra S; Bhattacharjee A
    J Biomol Struct Dyn; 2017 Jun; 35(8):1729-1742. PubMed ID: 27410776
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Synthesis of α-oxycarbanilinophosphonates and their anticholinesterase activities: the most potent derivative is bound to the peripheral site of acetylcholinesterase.
    Kaboudin B; Emadi S; Faghihi MR; Fallahi M; Sheikh-Hasani V
    J Enzyme Inhib Med Chem; 2013 Jun; 28(3):576-82. PubMed ID: 22397393
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Dual-target compounds for Alzheimer's disease: Natural and synthetic AChE and BACE-1 dual-inhibitors and their structure-activity relationship (SAR).
    Ferreira JPS; Albuquerque HMT; Cardoso SM; Silva AMS; Silva VLM
    Eur J Med Chem; 2021 Oct; 221():113492. PubMed ID: 33984802
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Discovery of Potent Dual Binding Site Acetylcholinesterase Inhibitors via Homo- and Heterodimerization of Coumarin-Based Moieties.
    Pisani L; Catto M; De Palma A; Farina R; Cellamare S; Altomare CD
    ChemMedChem; 2017 Aug; 12(16):1349-1358. PubMed ID: 28570763
    [TBL] [Abstract][Full Text] [Related]  

  • 60. (+)-Arisugacin A--computational evidence of a dual binding site covalent inhibitor of acetylcholinesterase.
    Al-Rashid ZF; Hsung RP
    Bioorg Med Chem Lett; 2011 May; 21(9):2687-91. PubMed ID: 21216144
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.